B2M and cancer: A thorough investigation into the association between B2M and different immunotherapy resistance, along with identifying effective strategies to reverse resistance caused by B2M defect (Figure 2), can not only significantly improve the clinical efficacy of immunotherapy but also potentially pave new avenues for overcoming resistance in cancer immunotherapy.